Family Medicine · Hermitage, TN
NPI
1710968037
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3939 Central Pike
Hermitage, TN, 37076
Phone (615) 883-2331
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
1,454 services
Medicare patients, 2024
188
Average age 71
Drug cost, 2024
$838K
7,554 prescriptions
Company payments, 2025
$2,882
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard Y Pak was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 226 times for 139 patients. In total Richard Y Pak billed 1,454 services in 42 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 226 | 139 | $10.01 | $2,262 |
| 99214 Office E&M - Established | Office | 212 | 126 | $66.34 | $14K |
| 85025 Blood Count | Office | 132 | 95 | $7.56 | $998 |
| 99213 Office E&M - Established | Office | 93 | 67 | $45.27 | $4,211 |
| 81003 Clinical Chemistry | Office | 54 | 41 | $2.20 | $119 |
| 96372 Injection Administration | Office | 52 | 12 | $6.01 | $312 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 43 | 13 | $40.61 | $1,746 |
| 82044 Clinical Chemistry | Office | 33 | 22 | $6.11 | $202 |
| 99204 Office E&M - New | Office | 22 | 22 | $67.83 | $1,492 |
By year: 2022 $34K for 930 services; 2023 $36K for 1,033 services; 2024 $32K for 1,454 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 132 | 95 | $7.56 | $998 |
| 81003 Clinical Chemistry | 54 | 41 | $2.20 | $119 |
| 82044 Clinical Chemistry | 33 | 22 | $6.11 | $202 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard Y Pak prescribed most often to Medicare patients was Atorvastatin Calcium, with 262 prescriptions and refills. In total Richard Y Pak wrote 7,554 Medicare prescriptions that cost $838K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 262 | 580 | 83 | $2,291 |
| Levothyroxine Sodium Generic | 247 | 546 | 67 | $1,892 |
| Lisinopril Generic | 225 | 537 | 69 | $1,378 |
| Ozempic Semaglutide | 194 | 220 | 32 | $207K |
| Metformin Hcl Generic | 191 | 412 | 52 | $1,440 |
| Omeprazole Generic | 176 | 375 | 52 | $2,024 |
| Alprazolam Generic | 172 | 172 | 26 | $1,002 |
| Amlodipine Besylate Generic | 167 | 420 | 56 | $795 |
| Gabapentin Generic | 165 | 253 | 39 | $2,735 |
| Rosuvastatin Calcium Generic | 160 | 353 | 45 | $2,085 |
| Furosemide Generic | 142 | 249 | 42 | $524 |
| Losartan Potassium Generic | 137 | 334 | 40 | $1,108 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 133 | 160 | 47 | $3,007 |
| Pantoprazole Sodium Generic | 129 | 247 | 27 | $1,576 |
| Trazodone Hcl Generic | 120 | 242 | 32 | $905 |
Brand drugs: 1,164 claims; generic drugs: 6,352 claims; opioid claims: 102.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard Y Pak $2,882 ($2,882 in general payments such as food, travel and fees) from 30 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $362.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $362 |
| Corcept Therapeutics CORT | 11 | $271 |
| Abbvie Inc. ABBV | 22 | $248 |
| Novo Nordisk Inc NVO | 17 | $245 |
| Pfizer Inc. PFE | 13 | $231 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $206 |
| GlaxoSmithKline, LLC. GSK | 8 | $153 |
| Amgen Inc. AMGN | 15 | $149 |
| Lilly USA, LLC LLY | 15 | $147 |
| Axsome Therapeutics, Inc. AXSM | 5 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.